Literature DB >> 6140358

Yersinia pseudotuberculosis septicaemia in thalassaemia major.

B Gordts, E Rummens, L deMeirleir, J P Butzler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6140358     DOI: 10.1016/s0140-6736(84)90198-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Yersinia pseudotuberculosis bloodstream infection and septic arthritis: case report and review of the literature.

Authors:  A J Kaasch; J Dinter; T Goeser; G Plum; H Seifert
Journal:  Infection       Date:  2011-07-26       Impact factor: 3.553

Review 2.  Report of four cases of Yersinia pseudotuberculosis septicemia and a literature review.

Authors:  P Ljungberg; M Valtonen; V P Harjola; S S Kaukoranta-Tolvanen; M Vaara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-09       Impact factor: 3.267

Review 3.  Benefits and risks of deferiprone in iron overload in Thalassaemia and other conditions: comparison of epidemiological and therapeutic aspects with deferoxamine.

Authors:  George J Kontoghiorghes; Katia Neocleous; Annita Kolnagou
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

4.  Haemochromatosis and aldosterone deficiency presenting with Yersinia pseudotuberculosis septicaemia.

Authors:  S P Conway; N Dudley; P Sheridan; H Ross
Journal:  Postgrad Med J       Date:  1989-03       Impact factor: 2.401

5.  Continuous subcutaneous insulin infusion in diabetes mellitus. A year's prospective trial.

Authors:  A G Davies; D A Price; C A Houlton; J L Burn; B A Fielding; R J Postlethwaite
Journal:  Arch Dis Child       Date:  1984-11       Impact factor: 3.791

6.  Yersinia pseudotuberculosis in a 3 year old and rapid response to cefotaxime.

Authors:  S J Nesbitt; L O Neville; F R Scott; D M Flynn
Journal:  J R Soc Med       Date:  1994-07       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.